Clinical Trials Browser

Phase 1 × Mesothelioma, Malignant × Indocyanine Green × Clear all

NCT03760575 2025-12-04

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Phase 1 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant